Results 81 to 90 of about 879,459 (400)

The severe presentation and poor outcomes of rheumatic heart disease in Namibia: Lessons from the REMEDY study

open access: yesSouth African Medical Journal, 2023
Background. This paper reports the baseline characteristics and outcomes of 266 Namibian patients in the Global Registry of Rheumatic Heart Disease. Objective.
T Auala   +9 more
doaj   +1 more source

Rheumatic Diseases and Heart

open access: yes, 2023
Rheumatic diseases are generally examined in three different classes; joint diseases, autoimmune connective tissue diseases, and vasculitides. They progress with significant cardiac involvement in all three groups. Cardiac involvement may present in a spectrum ranging from asymptomatic, mild, or subclinical to serious disease with a risk of mortality ...
Küçüker, Serhat, Pamukcu, Melih
openaire   +2 more sources

Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration

open access: yesArthritis Care &Research, Accepted Article.
Objective Though used frequently to treat flare, risk of chronic opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed chronic opioids over time.
Lindsay N. Helget   +7 more
wiley   +1 more source

The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead

open access: yesAdvanced Biology, EarlyView.
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi   +4 more
wiley   +1 more source

Coronary Artery Disease in Rheumatic and Non-Rheumatic Valvular Heart Disease

open access: yesJournal of Rawalpindi Medical College, 2018
Background:To study the prevalence of coronary artery disease (CAD) in patients undergoing valve surgery for rheumatic and non-rheumatic valvular heart disease.
Uzma Gul   +3 more
doaj  

Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda

open access: yesHeart, 2018
Background In sub-Saharan Africa, continued clinical follow-up, after cardiac surgery, is only available at urban referral centres. We implemented a decentralised, integrated care model to provide longitudinal care for patients with advanced rheumatic ...
Emmanuel Rusingiza   +11 more
semanticscholar   +1 more source

Photothermal Hydrogel with Mn3O4 Nanoparticles Alleviates Intervertebral Disc Degeneration by Scavenging ROS and Regulating Extracellular Matrix Metabolism

open access: yesAdvanced Functional Materials, EarlyView.
The MPTT‐nanozyme‐hydrogel system (Mn3O4@ChS‐HA) provides a multifunctional therapeutic strategy for intervertebral disc degeneration (IVDD), effectively targeting oxidative stress and enhancing AF repair by restoring extracellular matrix (ECM) and redox homeostasis.
Yangyang Chen   +13 more
wiley   +1 more source

Prevalence Of Rheumatic Fever and Rheumatic Heart Disease in School Children in Malwa Region Of MP

open access: yesNational Journal of Community Medicine, 2010
Rheumatic fever and rheumatic heart disease continue to affect   millions of people around the world. Children and adolescents of the developing countries are especially susceptible to this disease.
P. Yadav   +4 more
doaj  

Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis

open access: yesThe Lancet Global Health, 2023
Summary: Background: There is a dearth of evidence on the cost-effectiveness of a combination of population-based primary, secondary, and tertiary prevention and control strategies for rheumatic fever and rheumatic heart disease.
Jyoti Dixit, PhD   +6 more
doaj  

Home - About - Disclaimer - Privacy